Definitions and Core Concepts

Prev
 1 / 14 
Next
Prev
 1 / 14 
Next

Learning objectives

After completing this quiz, the learner should be able to:

  • define cold agglutinin disease (CAD) mechanistically
  • distinguish cold agglutinins from cold agglutinin disease
  • differentiate primary CAD from secondary cold agglutinin syndromes
  • explain the roles of complement, clonality, and thermal amplitude
  • identify what CAD is not and why this matters clinically

Which definition best describes cold agglutinin disease?

a
An autoimmune hemolytic anemia caused by cold exposure
Describes a trigger, not the disease mechanism.
b
A clonal, complement-mediated hemolytic disorder driven by IgM antibodies
Clonality, IgM, and complement define CAD.
c
A transient antibody-mediated anemia following infection
Describes post-infectious cold agglutinins, not CAD.
d
A splenic macrophage–mediated hemolysis responsive to steroids
Describes warm AIHA physiology, not CAD.

Which feature most clearly distinguishes cold agglutinins from cold agglutinin disease?

a
Presence of IgM antibodies
Many benign cold agglutinins are IgM.
b
Complement activation
Complement activation can be transient.
c
Monoclonality and persistence
Persistence and monoclonality define CAD.
d
Binding at low temperatures
Temperature-dependent binding alone is insufficient.

Which statement about hemolysis in CAD is most accurate?

a
Hemolysis is primarily intravascular via MAC formation
Terminal complement lysis is usually limited.
b
Red cell destruction occurs mainly in the spleen
Clearance is primarily hepatic, not splenic.
c
Hemolysis is antibody-dependent but complement-independent
Complement is central, not incidental.
d
Hemolysis is predominantly C3-mediated and extravascular
C3 deposition drives extravascular hemolysis.

Why is thermal amplitude clinically important in CAD?

a
It predicts response to steroids
Steroids target the wrong mechanism in CAD.
b
It correlates with in-vivo pathogenicity better than antibody titer
Thermal amplitude matters more than titer alone.
c
It determines whether hemolysis is intravascular
Hemolysis remains largely extravascular.
d
It reflects the size of the underlying B-cell clone
Clone size and thermal amplitude are not equivalent.

Which pattern most strongly supports primary CAD?

a
Recent respiratory infection with hemolysis
Suggests post-infectious cold agglutinins.
b
Polyclonal IgM cold agglutinins
Polyclonality argues against primary CAD.
c
Persistent hemolysis with monoclonal IgM production
This is the defining pattern.
d
Cold-induced acrocyanosis
Symptoms alone do not establish etiology.

Which direct antiglobulin test (DAT) pattern is most characteristic of CAD?

a
IgG negative, C3 positive
C3-only positivity is classic for CAD.
b
IgG positive, C3 negative
Typical of warm AIHA.
c
IgG positive, C3 positive
Suggests mixed AIHA or warm-predominant disease.
d
IgG negative, C3 negative
Does not support immune-mediated hemolysis.

Which underlying disorder most commonly drives primary CAD?

a
Plasma cell neoplasm
Plasma cell disorders are not typical drivers.
b
Aggressive B-cell lymphoma
Aggressive lymphomas may cause secondary syndromes.
c
T-cell lymphoma
Not associated with CAD pathogenesis.
d
Indolent B-cell lymphoproliferative disorder
Marrow-based indolent B-cell clones are typical.

Which statement about CAD is false?

a
CAD is reliably steroid-responsive
False: Steroids are typically ineffective in CAD.
b
CAD is primarily IgM-mediated
True.
c
CAD often involves an indolent marrow-based B-cell clone
True.
d
CAD is mechanistically distinct from warm AIHA
True.

Sort each feature into the correct category

Monoclonal IgM production
Persistent complement-mediated hemolysis
Frequently post-infectious
Associated with a clonal marrow disorder
Often polyclonal
Usually transient
Cold agglutinins (general)
Cold agglutinin disease

Match each concept to its clinical implication:

Thermal amplitude
Clonality
C3 deposition
Predicts in-vivo relevance better than titer
Drives extravascular hemolysis
Explains chronicity and treatment targets
Correct! Sorry, Incorrect.

Closing Note

Core principles for the module (foundational)

  • CAD is a complement disease before it is an anemia
  • Presence of antibodies ≠ presence of disease
  • Mechanism explains behavior, not the other way around

These principles are non-negotiable. Every treatment, sequencing, and judgment decision in the CAD module depends on them.

Prev
 1 / 14 
Next